PHEMI Closes $12.2 Million Venture Financing
August 11, 2015
VANCOUVER, BC – PHEMI, the company delivering security, privacy, and governance insights through the promise of big data, today announced it has raised a $12.2 million round of venture financing to expand the commercialization phase of the company. Secured by a combination of new and existing investors, the financing was co-led by CTI Life Sciences Fund (CTI) and British Columbia Discovery Fund (Discovery Capital) and included significant participation from early investors BDC Capital Healthcare Venture Fund and Yaletown Venture Partners.
A team of serial entrepreneurs, Dr. Paul Terry, Adam Lorant and John Seminerio—with expertise in developing and commercializing innovative business and technology solutions for a wide variety of industries, including healthcare, telecommunications, and high-performance computing—joined Chris Thompson and Alan Rabinowitz, two St. Paul’s Hospital cardiologists, in their start-up called PHEMI. With its initial focus in the healthcare and life sciences sectors, PHEMI will expand its focus to include a variety of data-driven communities, including public sector, insurance, and financial services.
In the news
Yaletown Partners would like to congratulate one of its portfolio companies, Tasktop, for entering into a definitive agreement to…
May 18, 2022
Yaletown Partners is pleased to report that Group14 Technologies, one of its portfolio companies, has completed a $400M Series C f…
May 6, 2022